Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma
Condition: Melanoma Interventions: Biological: Nivolumab; Biological: Pembrolizumab; Radiation: Radiation Therapy; Biological: Therapeutic Exchange Plasma Sponsors: Mayo Clinic; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Immunotherapy | Melanoma | Radiation Therapy | Research | Skin Cancer